Human papillomavirus vaccination uptake among Native Hawaiian and Pacific Islander adults in the United States
Menée à l'aide des données d'une enquête réalisée en 2014 auprès de 663 adultes (âge : 18-34 ans), cette étude identifie les facteurs associés à la vaccination contre le papillomavirus humain des jeunes adultes natifs d'Hawaï et des îles du Pacifique
Purpose: To examined HPV vaccination rates and identified factors that are associated with HPV vaccination among Native Hawaiian and Pacific Islander (NHPI) young adults aged 18-34. Methods: Data from the 2014 Native Hawaiian and Pacific Islander National Health Interview Survey were analyzed. The outcome variables were HPV vaccination initiation (receipt of ≥1 dose) and completion (receipt of ≥3 doses). Multivariable logistic regressions were used to identify socio-demographic, healthcare access and utilization factors that were associated with HPV vaccination. Results: A total of 663 adults were included in the study. The overall HPV vaccination initiation and completion rates were 17.6% and 7.9%, respectively. HPV vaccination initiation was higher among females than males (28.4% vs 7.2%; P<0.0001) and completion was also higher among females than males (13.7% vs 2.3%; P<0.0001). In the weighted multivariable models, compared with females, males were less likely to initiate (AOR=0.21, 95% CI=0.12, 0.34) and complete (AOR=0.16, 95% CI=0.07, 0.34) the HPV vaccination. Conclusions: The low HPV vaccination coverage found in this study signals the need for more evidence-based, culturally relevant immunization and cancer prevention interventions for NHPIs. Failure to improve HPV vaccination rates may increase the burden of HPV associated preventable cancers among NHPIs and broaden disparities.